Skip to main content

Microbialtec Supports Research with Sustainable Microbial Production with Fully Authenticated Microorganisms

By: Get News
Microbialtec announced the release of its microbial production to support the treatment of infectious diseases.

New York, USA - December 9, 2022 - Microbialtec is a high-tech service company that specializes in microbiological research-related issues. With years of experience and a professional technical team, Microbialtec is dedicated to assisting researchers in exploring the hidden mysteries between microbes and health, production, and the environment to make better use of microbial resources, covering all stages from microbial sample collection to detection and analysis. Recently, Microbialtec announced the release of its microbial production to support the treatment of infectious diseases.

Antibiotics are essential for treating human infectious diseases and are often used in agriculture to control the spread of disease in livestock and crops. Antibiotic production can be divided into three methods: natural fermentation, semi-synthesis, and synthesis. Semi-synthetic production of antibiotics is a combination of natural fermentation and laboratory work to maximize the use of antibiotics.

Multiple generations of selection and further propagation of high-yielding strains can greatly increase yields. Another technique used to increase yields is gene amplification, in which genes encoding enzymes involved in antibiotic production can be copied back into cells by vectors such as plasmids. This process must go hand in hand with antibiotic production and retesting of effectiveness. The microbes used in fermentation are rarely the same as wild microbes. This is because species are often genetically modified to produce the greatest amount of antibiotics. Mutations are frequently used and encouraged by the CRISPR/Cas9 genome editing approach.

With the emergence and spread of multidrug resistance, new antibiotics are urgently needed. Microbialtec is capable to begin therapeutic development research with strains known to produce antibiotics, including Penicillium, Streptomyces and Cephalosporium acremonium species.

In addition, Microbialtec offers other microbial production including:

Microbial Production of Enzymes: Enzymes produced by microorganisms are extensively studied worldwide for their isolation, purification and characterization of specific properties. As opposed to using chemical catalysts, microbial enzymes act as biocatalysts to carry out reactions in biological processes in an economical and environmentally friendly manner. Such microbial enzymes have demonstrated their utility in bioindustries such as food, leather, textiles, and animal feed, as well as in biotransformation and bioremediation.

Microbial Production of Biofuels: Microbes are abundant in most environments on Earth, and their use is driving a small but significant technological revolution. Microorganisms have the potential to provide the ethanol needed for many petroleum-derived products as well as liquid fuels. The role of the microorganisms that produce them is sure to become increasingly important.

"As experts in the field of microbiology, Microbialtec combines extensive project experience, strict data quality control and professional analysis processes to ensure accurate and fast service delivery." said Marcia Brady, the marketing director of Microbialtec, she also added, "Our team will design customized solutions to satisfy your specific requirements."

About Microbialtec Platform

As a division of Creative Biogene, Microbialtec platform has an experienced technical team involving molecular biology, medicine, bioinformatics, and statistical ecology. With 10 years of front-line scientific research experience, Creative Biogene supports customers with an overall microbiological research program and is capable to satisfy customized needs at affordable prices.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-386-8241
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.